MedTrace Logo

BIOFLOW-SV Portugal Registry

NCT03600961 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 173

Last updated 2024-02-15

No results posted yet for this study

Summary

Assessment of the clinical safety and performance of the Orsiro drug-eluting stent in a real world setting in patients with small vessels with reference vessel diameter ≤2.75 mm

Conditions

  • Ischemic Heart Disease

Interventions

DEVICE

Orsiro Sirolimus Eluting Coronary Stent System

Percutaneous coronary intervention

Sponsors & Collaborators

  • Biotronik AG

    lead INDUSTRY

Principal Investigators

  • Pedro Braga, MD · Centro Hospitalar de Vila Nova de Gaia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-05
Primary Completion
2020-12-30
Completion
2021-12-21

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03600961 on ClinicalTrials.gov